Sara Pel

955 total citations
17 papers, 117 citations indexed

About

Sara Pel is a scholar working on Infectious Diseases, Hematology and Rheumatology. According to data from OpenAlex, Sara Pel has authored 17 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Hematology and 5 papers in Rheumatology. Recurrent topics in Sara Pel's work include Autoimmune and Inflammatory Disorders Research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Sara Pel is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Sara Pel collaborates with scholars based in Israel, Netherlands and Slovenia. Sara Pel's co-authors include Ruud Segers, A. A. C. Jacobs, Ori Elkayam, Esther Saiag, Merav Heshin‐Bekenstein, Yosef Uziel, Nataša Toplak, Qi Cao, Vicky Fachinger and Eric Cox and has published in prestigious journals such as Annals of the Rheumatic Diseases, Vaccine and Lara D. Veeken.

In The Last Decade

Sara Pel

15 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Pel Israel 6 42 31 28 22 17 17 117
Frauke Metzler Germany 6 31 0.7× 7 0.2× 3 0.1× 21 1.0× 10 0.6× 6 510
Hanisah Sharif Brunei 7 9 0.2× 13 0.4× 6 0.2× 66 3.0× 3 0.2× 12 303
Kurt W. Roth Germany 7 39 0.9× 3 0.1× 10 0.4× 21 1.0× 6 0.4× 8 404
Amanda E. Brunton United States 7 130 3.1× 14 0.5× 9 0.3× 16 0.7× 15 0.9× 15 155
Cathleen Frein United States 4 57 1.4× 23 0.7× 1 0.0× 58 2.6× 30 1.8× 4 143
Ke Lin China 7 42 1.0× 2 0.1× 9 0.3× 13 0.6× 16 0.9× 11 98
Blandine Guffroy France 5 70 1.7× 16 0.5× 24 1.1× 23 1.4× 11 128
Joseph M. Rocco United States 9 126 3.0× 7 0.2× 2 0.1× 64 2.9× 24 1.4× 30 236
Frédérique Jossic France 5 62 1.5× 13 0.4× 36 1.6× 6 0.4× 15 198

Countries citing papers authored by Sara Pel

Since Specialization
Citations

This map shows the geographic impact of Sara Pel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pel more than expected).

Fields of papers citing papers by Sara Pel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pel. The network helps show where Sara Pel may publish in the future.

Co-authorship network of co-authors of Sara Pel

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Pel. A scholar is included among the top collaborators of Sara Pel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Pel. Sara Pel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Gertel, Smadar, Ari Polachek, David Levartovsky, et al.. (2024). Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseases. Lara D. Veeken. 64(4). 2233–2241. 1 indexed citations
3.
Hooijberg, Femke, Laura Boekel, Alwin D. R. Huitema, et al.. (2024). Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication. Therapeutic Drug Monitoring. 46(3). 410–414. 1 indexed citations
4.
5.
6.
Heshin‐Bekenstein, Merav, Nataša Toplak, David Hagin, et al.. (2022). Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications. Lara D. Veeken. 61(11). 4263–4272. 30 indexed citations
7.
Gertel, Smadar, Ari Polachek, Victoria Furer, et al.. (2022). T cell functions of psoriatic arthritis patients are regulated differently by TNF, IL-17A and IL-6 receptor blockades in vitro. Clinical and Experimental Rheumatology. 40(1). 120–128. 5 indexed citations
8.
Eviatar, Tali, Ofir Elalouf, Victoria Furer, et al.. (2021). Prevalence of COVID‐19 and seroprevalence to SARS‐CoV‐2 in a rheumatologic patient population from a tertiary referral clinic in Israel. Internal Medicine Journal. 51(5). 682–690. 3 indexed citations
9.
Eviatar, Tali, David Levartovsky, Victoria Furer, et al.. (2021). POS1206 SEROPREVALENCE OF SARS-CoV-2 ANTIBODIES IN AUTOIMMUNE INFLAMMATORY RHEUMATOLOGIC PATIENTS. Annals of the Rheumatic Diseases. 80. 885–886. 1 indexed citations
10.
Eviatar, Tali, Victoria Furer, Ari Polachek, et al.. (2021). Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases. Clinical and Experimental Rheumatology. 40(7). 1299–1305. 2 indexed citations
11.
Jacobs, A. A. C., et al.. (2020). Efficacy of a novel intradermal Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions. Porcine Health Management. 6(1). 25–25. 11 indexed citations
12.
Jacobs, A. A. C., et al.. (2019). Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions. Vaccine. 37(15). 2149–2157. 19 indexed citations
13.
Paran, Daphna, Yoav Smith, Uri Arad, et al.. (2018). Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatment. Current Medical Research and Opinion. 34(10). 1777–1783.
14.
Cox, Eric, et al.. (2016). Efficacy and safety of a new intradermal PCV2 vaccine in pigs. 5. 24–31. 17 indexed citations
15.
16.
Rozen, Paul, Irena Liphshitz, Guy Rosner, et al.. (2009). Pancreatic cancer in Israel: the epidemiology, possibilities of prevention, early detection and screening.. PubMed. 11(12). 710–3. 10 indexed citations
17.
Lurie, Yoav, et al.. (2007). Medex Test, a Novel Modality for Liver Disease Diagnosis. Journal of Clinical Gastroenterology. 41(7). 700–705. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frauke Metzler Breakdown of academic impact, for papers by Hanisah Sharif Breakdown of academic impact, for papers by Kurt W. Roth Breakdown of academic impact, for papers by Amanda E. Brunton Breakdown of academic impact, for papers by Cathleen Frein Breakdown of academic impact, for papers by Ke Lin Breakdown of academic impact, for papers by Blandine Guffroy Breakdown of academic impact, for papers by Joseph M. Rocco Breakdown of academic impact, for papers by Frédérique Jossic
Rankless by CCL
2026